Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Industry: Healthcare

Nextremity Solutions, Inc. Receives FDA 510(k) Clearance for Metatarsophalangeal Joint (MPJ) Arthrodesis System

Leave a comment


It is going to be a busy year for Nextremity Solutions and our surgeon teams with several additional 510(k) and product launches on deck.


WARSAW, Ind. (PRWEB)

Nextremity Solutions, Inc., a strategic commercialization organization with a focus on the extremity musculoskeletal space, located in “The Orthopedic Capital of the World,” Warsaw, Ind., today announced it has received 510(k) clearance by the Food & Drug Administration to market its upcoming InCore® MPJ System.

“The InCore platform continues to demonstrate its utility in foot and ankle applications. The InCore MPJ instrumentation provides built-in compression and positional stability to the fixation site prior to implant placement. Coupled with solid intraosseous implant fixation aimed to minimize hardware prominence, the InCore MPJ System presents a compelling solution for first MPJ fusion,” said Greg Denham, Director of Product Development, Early Intervention for Nextremity Solutions.

The InCore MPJ System joins the ever-expanding family of InCore products including the InCore Lapidus System for first TMT fusion and the InCore TMT System that is focused on second and third TMT fusion, which received 510(k) clearance earlier this year. The InCore MPJ system corrects deformity in the first metatarsophalangeal joint (MPJ). Pain in the first MPJ typically results from changes in tissue due to atypical foot biomechanics. Individuals usually suffer from this joint pain while walking and experience tenderness in the affected foot.

Ryan Schlotterback, Chief Technology Officer for Nextremity Solutions said, “We’re continuing to build momentum around our InCore technology platform. With elective surgeries opening back up and picking up steam, we are excited to introduce InCore TMT and InCore MPJ to the market. It is going to be a busy year for Nextremity Solutions and our surgeon teams with several additional 510(k) and product launches on deck. I’m proud of the team and the vigorous execution of our strategy – regardless of the external environment.”

President & CEO, Rod K. Mayer added, “I am very proud and thankful for the continued advancements our Nextremity Solutions team members deliver to the marketplace. We remain dedicated to solving unmet patient needs, providing repeatable outcomes for surgeons, and increasing shareholder value as we continue to develop new products.”

The Nextremity Solutions InCore MPJ System is a three-part construct intended for internal fixation for First Metatarsophalangeal Joint Arthrodesis (also known as 1st MPJ Fusion).

About Nextremity Solutions, Inc.

Nextremity Solutions, Inc. is a privately held strategic commercialization organization with a focus on the extremity musculoskeletal space, offering innovative solutions and Revenue Ready products for various extremity musculoskeletal applications and for the benefit of its industry partners. The Company’s procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

Share article on social media or email:

Health

NeoTract Designates Dr. Naveen Divakaruni as UroLift® Center of Excellence

Leave a comment


News Image

“This designation recognizes Dr. Naveen Divakaruni as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson


PLEASANTON, Calif. (PRWEB)

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Naveen Divakaruni, D.O., Advocate Medical Group in Aurora, IL, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Divakaruni has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Naveen Divakaruni as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction 1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Industry: Healthcare

JNL Technologies announces SafeHealth, a visitor screening tool

Leave a comment


SafeHealth screening software

SafeHealth screening software

“I love that this program is not just for Long Term Care; it can be used in any business.”


IXONIA, Wis. (PRWEB)

JNL Technologies Inc., a manufacturer of safety and security products for the Long Term care industry announced the release of the SafeHealth screening software. This tool allows companies to create an electronic screening record of anyone entering a property without the need for additional staff or the cost of additional paperwork management.

SafeHealth allows you to create a custom set of screening questions, allowing your business to comply with any specific local requirements. Employees follow the simple prompts on a touch screen kiosk to complete the screening, and the results are recorded electronically. SafeHealth also allows for multiple kiosks to operate together, streamlining the entry process. SafeHealth was designed to work as a stand-alone system or in conjunction with other screening tools including JNL’s existing Quantum safety and security product line.

According to JNL’s President, James Gleason, “The changes in the world today surrounding infection control have our customers searching for ways to screen anyone entering their buildings, and document that screening. Many feel that this is the new normal and will continue long after COVID-19 is controlled.” James also stated that, “I love that this program is not just for Long Term Care; it can be used in any business.”

You can easily expand your screening capabilities by adding a Temperature Screening Station and Quantum’s Door Control System.

SafeHealth is offered by JNL’s certified dealer network. Learn more at safehealthscreen.com. Contact JNL Technologies at 262-244-7409 or email sales@jnltech.net

About JNL Technologies

JNL is a leading provider of nurse call and resident monitoring technology in the senior housing market. With over 25 years of hands-on experience in aging, health care, nurse call, remote monitoring and wander management technology, JNL has created Quantum, a unique and seamless nurse call, access control, and wander management system. Using a network of vetted and trained partners, JNL offers full-featured senior safety technology to long-term care communities throughout the United States. For more information, visit jnltech.net, or contact sales@jnltech.net

Share article on social media or email:

Health: Mental Health

NorthShore provides real time genomic decision support to 10,000 patients using the ActX Service

Leave a comment


Our vision has always been to provide easy-to-use genomic decision support, with the goal that it would one day become a standard in patient care. I am elated that NorthShore shares this vision.


SEATTLE (PRWEB)

For many years, NorthShore University HealthSystem (NorthShore) has been one of the leaders in personalized medicine. In 2016, they implemented ActX Genomic Decision Support inside Epic. Now, NorthShore has partnered with ActX to complete their largest genomics program to date.

NorthShore has taken an additional 10,000 patients through genetic testing as part of the DNA-10K initiative. Once genetic testing was completed, the discrete genetic data was loaded into the ActX platform and made available in Epic, NorthShore’s electronic health record. Prescriptions for select medications ordered inside Epic are checked in real time against the patient’s genetics, and the clinician is alerted if there are issues with side effects, efficacy, or dosing, all in routine Epic workflow. A genomic profile for each patient is built into the Epic medical chart.

DNA-10K has already seen tremendous success, with 99% of NorthShore’s eligible physicians ordering tests for their patients. In an internal survey of physicians who ordered the test for their patients, more than half said the program has already provided a direct clinical benefit to their patients. Plus, 99.8% of tested patients had at least one actionable finding associated with pharmacogenomics, which could become relevant later in life (as new prescriptions are needed).

“At NorthShore our goal is to ensure every patient who can benefit from pharmacogenomics will benefit from it no matter where they are receiving care in the system. We continue to progress on this goal as a part of the Mark R. Neaman Center for Personalized Medicine. ActX has been a key partner to drive pharmacogenomics data into clinical care,” said Mark Dunnenberger, PharmD, director of personalized medicine and pharmacogenomics at NorthShore.

“The ActX platform helps make genomics actionable, a key part of which is pharmacogenomics, in everyday medical practice,” said Dr. Andrew Ury, CEO of ActX. “Our vision has always been to provide easy-to-use genomic decision support, with the goal that it would one day become a standard in patient care. I am elated that NorthShore shares this vision, and we are thrilled to be a part of their genomics program.”

About ActX

ActX is the industry leader in EHR-integrated precision medicine. Our service helps physicians make better decisions about medical treatment, using a patient’s genetic information to guide therapy. The ActX Genomic Service offers proven, tightly integrated, real-time genomic decision support for medication orders and actionable genomic risks, a built in patient Genomic Profile, and the ability to fully customize content.

As medications are ordered, and before the prescription is finalized, medications are checked against the patient’s genetics for efficacy, adverse reactions, and dosing. Extensive evidence based and actionable content is provided as default, customizable content, covering hundreds of genes. You can easily suppress any content or interactions, or add or modify content. The ActX Genomic Service is live at numerous Epic customers. For more information, visit http://www.actx.com, email info@actx.com or call 888-998-2289.

About NorthShore University HealthSystem

NorthShore University HealthSystem (NorthShore) is an integrated healthcare delivery system consistently ranked a Top 15 Major Teaching Hospital in the U.S. Headquartered in Evanston, Illinois, NorthShore includes five hospitals – Evanston, Glenbrook, Highland Park, Skokie and Swedish, 140 care sites and 2,300 physicians, serving over 635,000 patients. For more information, please visit http://www.northshore.org and http://www.swedishcovenant.org.

Share article on social media or email:

Health

LIFT Foundation – Winning Big While Helping Others In Need

Leave a comment



NEWPORT BEACH, Calif. (PRWEB)

The Orange County based non-profit organization, LIFT Foundation was recently honored by AssetMark, Inc. at their Gold Forum Community Inspiration Awards. Chris Vizzi, Founder of the LIFT Foundation will be distributing the $10,000 awarded by AssetMark, Inc. to two non-profit organizations that the LIFT Foundation supports: Project Self-Sufficiency & The Mercy Warehouse. The funds will be used to advance their programs and assist those most impacted by the COVID-19 pandemic.

“Part of the mission of the LIFT Foundation has always been to financially and emotionally support those in most need and commit resources to those who have fallen victim to hard times,” comments Mr. Vizzi. He adds, “Now during this unique time, we face an unprecedented challenge amidst this global pandemic and LIFT is well positioned to support the Orange County community through our network of dedicated volunteers and spirit of unity.” He concludes, “On behalf of all of us at LIFT, we extend our gratitude and thanks to AssetMark’s Community Inspiration Awards for honoring LIFT and celebrating our dedicated and passionate partners.”

“We are so grateful for the efforts the LIFT Foundation has made on our organization’s behalf,” explains Beth Jackson-Prado, Executive Director of the Newport Beach based non-profit, Project Self Sufficiency. She adds, “Our Stairway to Success program – focused on teaching real-life finance and business skills – has been a tremendous success thanks to LIFT and Chris’ leadership.”

About The LIFT Foundation

The LIFT Foundation, a non-profit 501(c)(3), was founded by Chris Vizzi in 2013. LIFT’s primary goal was to address the growing disparity between the rich and poor in Orange County, California. Over time, the vision evolved to partner with multiple organizations that focus on a variety of causes, including the education of at-risk homeless children, feeding the hungry and the empowerment of single mothers facing grave financial hardships. Their award-winning work was recently featured by Barron’s Magazine and has been honored by Project Self Sufficiency for their pivotal fundraising efforts over the past year. The LIFT Foundation’s signature golf event takes place at The Monarch Beach Resort in Dana Point on October 1, 2020. To learn more about LIFT, please visit http://www.liftfoundation.us.

About Chris Vizzi, CFP®

Chris Vizzi is a Certified Financial Planner and a co-founding partner with South Coast Investment Advisors. He is an NFLPA Registered Player Financial Advisor and is the youngest to have earned the coveted Elite Advisor Award with his affiliated broker-dealer, Independent Financial Group. Chris holds his bachelor’s degree in Business Economics with an emphasis in Accounting from the University of California, Santa Barbara. Chris specializes in retirement and estate planning, risk management, asset allocation, and tax planning. Chris holds FINRA Series 7 and 66 licenses as well as his California Life and Health Insurance license. To learn more about Chris and his team, please visit https://southcoastinvest.com/.

Share article on social media or email:

Industry: Healthcare

Casenet LLC Releases Fully Revamped TruCare 2020 Platform

Leave a comment


TruCare 2020 screenshot

TruCare 2020’s new User Interface is now available.

With TruCare 2020, our clients can expect to receive the exceptional implementation and client service they are used to, while also enjoying enhanced usability, system-to-system interoperability and TruCare Insights.


BEDFORD, Mass. (PRWEB)

Casenet® LLC today released TruCare 2020, an HTML5 version of its award-winning population health management platform that supports care management and utilization management at health insurance plans. Developed over two years with input from more than 100 individuals at client sites, TruCare 2020 provides significant usability and automation upgrades to all of its existing features, introduces more system-to-system integration, and offers TruCare Insights, a suite of management tools.

“With TruCare 2020, our clients can expect to receive the exceptional implementation and client service they are used to, while also enjoying enhanced usability, system-to-system interoperability and TruCare Insights,” said Peter Masanotti, Chief Executive Officer of Casenet, LLC. “Additional extensibility and interoperability bring opportunities for new efficiencies, so we focused on positioning TruCare 2020 to help make it possible for a plan’s systems to talk to one another in real-time, built room for robotic capabilities, and ensured staff are saving time when using the system.”

TruCare Insights, developed by Casenet’s Advanced Solutions Group, is a new companion application that provides a suite of action-oriented dashboards and management tools for leaders to monitor and manage their operation and teams’ work. TruCare Insights aggregates TruCare data and allows users to filter, group, and sort information as well as monitor, update, reassign tasks and activities, and message users from within the application.

TruCare 2020 continues the product’s history of excellence in identifying and segmenting populations based on risk while enabling care managers to quickly implement clinical programs that promote wellness, prevent disease, manage chronic conditions, and coordinate care. TruCare 2020’s improvements support strategically important affordability and quality initiatives with enhanced product usability and visibility across the health plan workforce.

Casenet population health technology solutions are used by top health plans to manage more than 33 million health plan members in the United States. Ranked Best in KLAS in 2017, 2018, and 2019, Casenet is well known for innovation, implementation, and client service. The TruCare platform offers care management, disease management and utilization review, and integrates with best-in-breed partner solutions for enhanced evidence-based content, analytics, and portals.

About Casenet, LLC

Casenet provides a comprehensive suite of enterprise care management software and services solutions for commercial, Medicaid, Medicare, TPA, provider/ACO and specialty provider organizations that have multiple lines of business and that require comprehensive configurations for each member population. Healthcare organizations rely on Casenet’s population health management solutions to improve care coordination and the quality and delivery of care through enhanced case, disease, utilization, and home and community-based services management. Casenet solutions enable organizations to adapt quickly to changing market and regulatory dynamics, and to identify and target populations having unique risk characteristics with specific care management programs— taking the first step toward better individual health and total population health management. For more information, visit https://www.casenetllc.com.

Share article on social media or email:

Health

Corona SeroStatus App Launches, Leverages Blockchain and Testing to Offer a Pathway to Reopen Economies While Protecting User Privacy

Leave a comment



FRANKFURT, Germany (PRWEB)

Today Anyblock Analytics, a German firm noted for its enterprise blockchain expertise, announced the launch of the Corona SeroStatus app. Many facilities, cities, states/provinces, and countries are eager to begin re-opening their economies. Yet with more than 4.7 million confirmed cases of coronavirus globally—including nearly 1.5 million in the United States alone—serious concerns remain about how to do so safely. The SeroStatus app offers a solution that’s easy to use and which avoids the pitfalls of cybersecurity and data privacy issues with contact tracing apps and central databases.

“As stay-at-home restrictions start to relax and businesses start to re-open, there’s a lot of concern about how to be smart about it, so that we don’t see a new spike in coronavirus cases,” explained Jens Griesing, co-founder of the SeroStatus app. “Unlike contact tracing that attempts to notify individuals if they might have been exposed to coronavirus from a person who tested positive, the SeroStatus app tells who does or doesn’t pose a risk based on actual test results. And we do this while protecting individuals’ data privacy.”

Using the SeroStatus app is simple—if you know how to take a selfie and scan a QR code, you can use the app. Here’s how it works:

  • First, a user takes a selfie or scans a photo ID.

  • Second, the user visits an approved medical professional. The medical professional can thus confirm that the person in the phone’s app and the person in front of them are one and the same.

  • Next, the user takes the chosen medical test, such as a coronavirus rapid test or an antibody test.

  • Once the test results come in, the medical professional enters the result into their app and securely transfers it to the user via a unique QR code. Now the test results ‘lives’ on the user’s phone, not in a central database.

  • Finally, venues can screen individuals and admit or deny entry. The venue scans the user’s QR code and sees the result, without accessing the user’s private information.

The versatile app can document who’s healthy (such as via a negative rapid test) as well as who’s recovered from previous exposure (via a positive antibody test). This is crucial information for intelligently reopening businesses, venues, and services, including:

  • Hospitals and other healthcare facilities concerned about employees and visitors,

  • Major office buildings with hundreds or even thousands of employees,

  • Meat-packing plants, factories, and other industrial facilities, and

  • Casinos, conference hotels, sporting arenas and stadiums, and other large event venues


Just as importantly, the SeroStatus app does this with a decentralized approach—in part using blockchain technology—that protects user data. Approved medical professionals attest users’ results, which are securely stored on a person’s mobile phone without a central cloud database that could be manipulated or hacked. Venues scan a user’s phone to confirm the results and approve or deny entry, without the user ever having to compromise sensitive personal information. This is another key distinction between the SeroStatus app and other approaches that use a central or even government-controlled database. With SeroStatus, everyone is in charge of their own data, while keeping that data accurate so venues can be confident in the results.

For more details on the investment opportunity or to find out how to roll this out in your region, please visit https://www.serostatus.com/ or learn more in our explainer videos.

About Anyblock Analytics

Anyblock Analytics GmbH is a German blockchain solution provider with the mission to build bridges between different organizations, across various blockchain networks and most importantly between people. Anyblocks Analytics GmbH offers methods, tools and data to integrate business processes with blockchain. The solution portfolio comprises a complete set of products and services for enterprise blockchain use cases on both public and private consortia chains.

Contact

Nicole Arnone

+1.770.856.7185 | nicolearnone@inflectionpointagency.com

Share article on social media or email:

Industry: Healthcare

Clarion Safety Systems Offers New COVID-19 Safety Products

Leave a comment


Today’s best practice workplace safety signs – in contrast to older, out-of-date styles – use ANSI designs, ISO graphical symbols, and offer critical details to help keep workers safe.

Signage isn’t just a quick fix to satisfy regulatory requirements. Signs that use today’s ANSI and ISO best practices can help workplaces to meet and exceed safety goals and risk objectives. That’s important every day, but especially in our COVID-19 environment.


MILFORD, Pa. (PRWEB)

Clarion Safety Systems, a leading manufacturer of safety labels, signs and tags, has expanded its product line to offer a full portfolio of COVID-19 safety products. These new visual safety solutions can help businesses to keep employees, visitors and customers safe by supporting social distancing policies, reminding of hygiene protocols, and reinforcing PPE requirements.

“We’ve always taken our role in providing effective visual safety communication products extremely seriously. After all, not only is hazard communication fundamental in reducing risk to workers, it also helps to keep companies in compliance with applicable codes and standards, allowing them to continue to make their products and services available,” says Ron Crawford, CEO of Clarion Safety.

“During these unprecedented times, the part that our company plays in product and workplace safety has taken on an even more amplified meaning. That’s why we took early steps necessary to stay fully operational over the past months to support the needs of our customers; many of them are in essential industries like medical equipment manufacturing, chemical processing and distribution, supplying life-saving resources to combat COVID-19. And it’s why we’re offering this new line of workplace safety products, especially critical right now to support the needs of shuttered facilities that are beginning the process of reopening.”

Clarion Safety’s New Product Line

As essential businesses expand production in response to the reopening economy, and as workplaces that faced closures due to the pandemic look to resume some level of in-person operations with quarantines being pealed back, safety is paramount. The Centers for Disease Control and Prevention (CDC), Occupational Safety and Health Administration (OSHA), and local health agencies help to establish guidelines to follow, many of which can be supported by signs, labels and floor markers. Clarion Safety’s new product line is specifically designed to support back to work plans in helping to stop the spread of the virus. For example, the solutions contain messaging to inform visitors of curbside pickup instructions, to remind workers how best to disinfect hands, and to communicate general safety precautions like maintaining social distancing and wearing a face mask. Clarion Safety’s COVID-19 safety label and sign products include:


  • Wash Your Hands Signs

  • Virus Prevention Tip Signs

  • Virus Symptom Awareness Signs

  • PPE-related Labels

  • PPE-related Signs

  • Quarantine-related Signs

  • Please Stand Here Floor Markers

  • Social Distancing Notice Signs

  • Curbside Pickup Signs

Visual Safety Best Practices for Today’s Workplaces

Clarion Safety specializes in designing safety signs that are not only compliant with OSHA regulations, but use the latest American National Standards Institute (ANSI) and International Organization for Standardization (ISO) warnings technology to more effectively create awareness and explain hazards specific to the issue at hand. The company’s COVID-19 notice, caution and warning signs use ANSI Z535-style designs as well as ISO standardized graphical symbols. The style of these signs offer critical detail to help keep workers safe.

“OSHA currently only stipulates minimal requirements – the most basic level – for sign content and design. These simplified formats are common in today’s workplaces, but they’re not the only choice. The best practice principles offered in the ANSI and ISO standards are considered the state-of-the-art for today’s warnings,” says Angela Lambert, Clarion Safety’s Director of Standards Compliance. In addition to having fifteen years of warnings and liability experience, Lambert is actively involved at the leadership level in the ANSI and ISO standards. That includes a recent nomination as chair of ANSI Z535.1, a standard that focuses on safety colors, including those used in safety signs, labels, tags and markings.

“Signage isn’t just a quick fix to satisfy regulatory requirements. It can help workplaces to meet and exceed safety goals and risk objectives. By choosing signs that are up-to-date with today’s ANSI and ISO best practices, workplaces are doing everything they can to move towards a safer, more productive environment. That’s important every day, but especially so in our COVID-19 environment.”

Old Versus New Ways to Warn

Many safety professionals are unaware of the progress made in safety sign design standards over the past decade, leading to safety signs being out of sync with today’s best practices.

Outdated signs typically do not use graphics or symbols, do not use signal words appropriate to the level of risk and lack substantive information. New, best practice signs, in contrast, use colorful ANSI formats to attract attention, use proper risk level signal words, use standardized graphical symbols to help communicate across language barriers and show more complete information, helping people to make better, safer decisions.

“Whether a company’s objective is to meet ANSI/ISO best practices, OSHA regulations or CDC/WHO guidelines, our team is here to help. We offer a full catalog of safety signs, as well as online resources and a free assessment service, where our trained professionals review a facility’s signage and make recommendations for improvements,” says Lambert.

To learn more about safety sign best practices, visit Clarion Safety’s online Resource Center.

Clarion Safety also accepts media inquiries and speaking opportunities related to workplace safety and risk and visual communications best practices. To submit a media inquiry, visit the company’s “Newsroom” and select the “For the Media” tab.

ABOUT CLARION SAFETY SYSTEMS

Clarion Safety Systems, LLC, is the leading designer and manufacturer of visual safety solutions that help customers in more than 180 industries worldwide to make their products and premises safer. Clarion offers a full range of standard and custom products including machinery safety labels, environmental and facility safety signs, pipe and valve identification markings, lockout/tagout products, and safety-grade photoluminescent egress path-marking escape systems. Founded in 1990, the company continues to play a leading role in the development and writing of international and national standards for safety signs, labels, and markings. Clarion is headquartered at 190 Old Milford Road in Milford, PA, 18337, and online at http://www.clarionsafety.com.

Share article on social media or email:

Health

MedVet Opens Emergency and Critical Care Veterinary Hospital in Mountain View

Leave a comment


News Image

“MedVet Mountain View will provide an important step towards greater access to specialty and emergency care for the community,” said Dr. Linda Lehmkuhl, Chief Executive Officer of MedVet.


MOUNTAIN VIEW, Calif. (PRWEB)

MedVet, a leader in emergency and specialty veterinary healthcare, is set to open an emergency and critical care veterinary hospital located at 601 Showers Dr., Mountain View, CA in June 2020. MedVet Mountain View joins existing MedVet hospitals in Campbell and Silicon Valley to further expand access for pet care in the Silicon Valley and broader Santa Clara County areas. Concurrent to opening MedVet Mountain View, MedVet San Jose will permanently transition emergency and critical care veterinary services to MedVet Campbell, located at 905 Dell Ave., Campbell, CA 95008.    

“Santa Clara County has been an incredibly supportive community and we’re excited to be expanding our services under the leadership of Monica Clare, VMD, Diplomate, ACVECC and Robyn Baillif, RVT, VTS (ECC),” said Dr. Linda Lehmkuhl, Chief Executive Officer of MedVet. “MedVet Mountain View will provide an important step towards greater access to specialty and emergency care for the community. We look forward to continued and new partnerships with local community veterinarians as we support their patients’ and clients’ emergency care needs.”

“MedVet Mountain View will be open weeknights, weekends, and holidays as an extension of our local community veterinarians if they are unavailable. We are excited to offer state-of-the-art emergency medicine and critical care to cats and dogs,” said Dr. Monica Clare, Medical Director of MedVet Mountain View.

For pets that require specialty care, MedVet Mountain View will collaborate with MedVet Silicon Valley with services in cardiology, internal medicine, medical oncology, neurology & neurosurgery, and surgery and MedVet Campbell, offering emergency medicine, critical care, and cardiology specialty services. All three MedVet locations will work together to coordinate care based on the individual needs of the pets and families they serve.

MedVet Mountain View is located at 601 Showers Dr., Mountain View, CA 94040, and can be reached by phone at 408.578.5622, fax 650.494.0753, and email info.mountainview@medvet.com.

ABOUT MEDVET

Veterinarian led and owned since 1988, MedVet is a growing nationwide network of hospitals committed to delivering the highest quality, most compassionate specialty and emergency veterinary care , working in partnership with general practice veterinarians as an extension of their care team. More than 2,300 team members, working in 29 locations throughout the United States to enhance the lives of pets, their loving families, and the veterinary community, helping to advance MedVet’s mission of Leading Specialty Healthcare for Pets. MedVet serves more than 335,000 pets and their families and more than 7,500 referral partners each year.

Media Contact:

Sarah Berger

Vice President, Marketing

sarah.berger@medvet.com

513.205.7759

Share article on social media or email: